Novel plasmid-mediated extended spectrum beta-lactamases
- 31 May 1992
- journal article
- research article
- Published by Elsevier in Infectious Diseases Newsletter
- Vol. 11 (5), 33-37
- https://doi.org/10.1016/0278-2316(92)90043-d
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- More extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1991
- Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1990
- Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facilityAntimicrobial Agents and Chemotherapy, 1990
- Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1989
- Extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1989
- Plasmid-Mediated Resistance to Third-Generation Cephalosporins Caused by Point Mutations in TEM-Type Penicillinase GenesClinical Infectious Diseases, 1988
- Plasmid-Mediated -Lactamase (TEM-7) Involved in Resistance to Ceftazidime and AztreonamClinical Infectious Diseases, 1988
- Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitorsAntimicrobial Agents and Chemotherapy, 1988
- Bacterial Resistance to β-Lactam Antibiotics: Crystal Structure of β-Lactamase from Staphylococcus aureus PC1 at 2.5 Å ResolutionScience, 1987
- Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescensInfection, 1983